涎腺淋巴上皮癌的治疗现状研究进展  

Advances in research of the treatment of lymphoepithelial carcinoma of salivary glands

作　　者：林叔陈[1] 傅深[1] 

机构地区：[1]上海交通大学附属第六人民医院肿瘤放疗科,上海200233

出　　处：《现代肿瘤医学》2015年第10期1463-1466,共4页Journal of Modern Oncology

摘　　要：涎腺淋巴上皮癌是一种伴有淋巴间质浸润的未分化癌,发病率低,其发病与EB病毒感染、免疫反应、良性淋巴上皮病变等因素有关。近年来研究证实,涎腺淋巴上皮癌是一种放射治疗敏感肿瘤,手术联合术后放射治疗为本病治疗的常用模式,获得了良好的局部控制率及无病生存率。Lymphoepithelial carcinoma of salivary glands is known as undifferentiated carcinoma with lymphoid stroma. It is rather rare and Epstein - Barr virus infection, immune response and benign lymphoepithelial lesions have been implicated in the pathogenesis of this disease. Recent studies suggested that it is a highly radiosensitive disease and surgery and post - operative radiotherapy is a mainstay of treatment for this disease with satisfactory locoregional control and disease free survival.

关 键 词：淋巴上皮癌 EB病毒 放射治疗 

分 类 号：R739.87[医药卫生—肿瘤]